Ipsen has appointed Asad Mohsin Ali as general manager of its UK & Ireland affiliate. Asad has spent over two decades driving innovation and commercial growth across the pharmaceutical industry. Most recently, since 2016 he has been acting as VP and general manager for the UK, Ireland and Nordics at TESARO, specialising in oncology and overseeing the launch and successful UK reimbursement of its cutting-edge PARP inhibitor in recurrent ovarian cancer. Prior to his time at TESARO Asad spent 17 years at Novartis working across various global and country roles including in the UK, Switzerland and Mexico.